STOCK TITAN

Akoya to Participate at Three Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Akoya Biosciences, Inc. (Nasdaq: AKYA) will be participating in three upcoming investor conferences: Stephens Annual Investment Conference, Canaccord Genuity 2023 MedTech, Diagnostics and Digital Health & Services Forum, and Piper Sandler 35th Annual Healthcare Conference. The fireside chats will cover various topics related to the company's spatial biology solutions. The events will be webcasted live and archived on the Akoya website.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in three upcoming investor conferences.

  • Stephens Annual Investment Conference | NASH 2023
    Fireside Chat on Wednesday, November 15th at 11:00 AM CT
    Nashville, TN
  • Canaccord Genuity 2023 MedTech, Diagnostics and Digital Health & Services Forum
    Fireside Chat on Thursday, November 16th at 2:30 PM ET
    New York, NY
  • Piper Sandler 35th Annual Healthcare Conference
    Fireside Chat on Thursday, November 30th at 11:30 AM ET       
    New York, NY

A live and archived webcast of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com 


FAQ

What investor conferences will Akoya Biosciences be participating in?

Akoya Biosciences will be participating in the Stephens Annual Investment Conference, Canaccord Genuity 2023 MedTech, Diagnostics and Digital Health & Services Forum, and Piper Sandler 35th Annual Healthcare Conference.

What topics will be discussed during the fireside chats?

The fireside chats will cover various topics related to Akoya Biosciences' spatial biology solutions.

Where can I access the webcast of the events?

The webcast of the events will be available on the 'Investors' section of the Akoya website at https://investors.akoyabio.com/.

Akoya Biosciences, Inc.

NASDAQ:AKYA

AKYA Rankings

AKYA Latest News

AKYA Stock Data

138.78M
17.38M
12.87%
72.24%
2.01%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
MARLBOROUGH

About AKYA

akoya biosciences is developing a novel high-parameter tissue analysis platform, at an order of magnitude beyond what is currently possible. our codex (tm) (co-detection by indexing) system enables deep proteomic profiling.​..all on your existing microscope​. if you are a scientist or software engineer interested in revolutionizing the science of imaging, then akoya is the place for you. contact is at info@akoyabio.com.